Markets

Kraken Robotics Shares Rebound Amid Covelya Deal Anticipation

Kraken Robotics shares surged 8.9% Monday, rebounding from Friday's drop, as market participants look for progress on the C$615 million Covelya acquisition.

Daniel Marsh · · · 3 min read · 1 views
Kraken Robotics Shares Rebound Amid Covelya Deal Anticipation

Kraken Robotics Inc. saw its stock price climb sharply on Monday, recovering from losses at the end of the previous week. Shares of the Canadian defense and marine technology company traded up 8.9% to C$7.94 on the TSX Venture Exchange by midday, with trading volume reaching approximately 576,260 shares. The move came without any fresh corporate announcement, leaving investors focused on the pending C$615 million acquisition of Covelya Group.

Market Context and Trading Activity

The stock opened at C$7.35 and reached an intraday high of C$7.94 before settling. Monday's bounce partially reversed Friday's 4.95% decline, which had pushed shares to C$7.29. Despite the rebound, the stock remains well below its March 2026 high of C$10.72, indicating continued volatility. Canadian markets operated as usual on Memorial Day, while U.S. exchanges were closed.

Covelya Acquisition in Focus

The primary catalyst for investor attention remains the planned acquisition of Covelya Group, a deal valued at C$615 million. Kraken agreed in March to pay C$480 million in cash and C$135 million in shares for the company, which owns several underwater technology firms including Sonardyne, EIVA, Forcys, Wavefront Systems, Voyis Imaging, and Chelsea Technologies. To finance the cash portion, Kraken raised C$402.5 million in March through a public offering of subscription receipts at C$8.50 each. These receipts will convert into common shares upon deal completion, or investors will receive their money back plus interest if conditions are not met by December 31, 2026.

Company Fundamentals and Guidance

Kraken Robotics specializes in subsea sensors, batteries, and robotic tools for defense, offshore energy, and marine science applications. Its key products include synthetic aperture sonar (SAS) for high-resolution seafloor imaging and SeaPower batteries. The company reported record revenue of C$102.2 million for 2025, with adjusted EBITDA of C$25.0 million. For 2026, Kraken issued guidance calling for revenue between C$165 million and C$175 million and adjusted EBITDA in the C$40 million to C$50 million range, excluding the Covelya acquisition.

Recent Orders and Partnerships

On April 16, Kraken announced approximately C$28 million in new orders for SeaPower batteries and SAS systems from five clients, including two new customers. CEO Greg Reid cited "significant demand for our products and services" and a "surge in demand for maritime drones" as defense and energy clients increasingly adopt uncrewed systems. Additionally, on May 6, Kraken signed a memorandum of understanding with SEFINE SISAM in Türkiye to integrate its KATFISH sonar system into mission-planning software and develop automatic target recognition capabilities for seabed warfare and mine countermeasures.

Broader Market Influence

The broader Canadian market also provided a positive backdrop, with the S&P/TSX Composite Index climbing 0.7% to a record high of 34,778.98, fueled by hopes of progress in U.S.-Iran talks. Brian Madden, chief investment officer at First Avenue Investment Counsel, noted that "even a non-zero chance the conflict ends" was enough to boost stocks and lower oil prices, though he cautioned that the market is not fully convinced.

Risks and Outlook

While Monday's bounce offered some relief, risks remain. The Covelya deal is subject to regulatory approvals and customary closing conditions. Any delays or weaker-than-expected orders could undermine the rally. Kraken must successfully integrate a larger team and demonstrate that its guidance translates into actual revenue and cash flow. Investors will be watching closely for updates as the second-quarter closing target approaches.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.